? ?Lidocaine Hydrochloride (CAS 73-78-9) | Pharmaceutical-Grade Local Anesthetic & Antiarrhythmic Agent? ?

?? ?Product Overview?

?Lidocaine Hydrochloride? (CAS 73-78-9) is a widely used ?amide-class local anesthetic? and ?antiarrhythmic drug? with the molecular formula ?C??H??N?O·HCl? and a molecular weight of ?270.80?. This white crystalline powder (purity ≥99%) is essential for pain management in clinical settings and serves as a critical intermediate in pharmaceutical manufacturing. It provides rapid, reversible nerve blockade and stabilizes cardiac membranes in arrhythmia treatment.

?Key Functions?:

• Induces local anesthesia for surgical and diagnostic procedures.

• Reduces ventricular arrhythmias in emergency care.

• Acts as a reference standard in drug quality control.

?Target Industries?: Pharmaceuticals, hospitals, and research laboratories.

? ?Key Advantages?

?? ?Applications?

• ?Local Anesthesia?

  : Topical creams, sprays, and injectables for minor surgeries.

• ?Cardiac Care?

  : Intravenous administration for arrhythmia control.

• ?Pharmaceutical R&D?

  : Impurity profiling and API synthesis.

?? ?Quality Assurance?

• ?Testing Standards?

  : Complies with 

  ?USP/EP?

   pharmacopeial requirements.

• ?Analytical Methods?

  : HPLC, NMR, and mass spectrometry validation.

• ?Certifications?

  : ISO 9001 and GMP compliance for pharmaceutical use.

?? ?Market Insights?

The global local anesthetics market is projected to grow at ?6.1% CAGR (2025–2030)?, driven by rising surgical volumes and demand for minimally invasive therapies. Lidocaine remains a cornerstone in emergency medicine, with Asia-Pacific emerging as a key growth region due to expanding healthcare access.